VANTIVE Trademark

Trademark Overview

On Monday, July 24, 2023, a trademark application was filed for VANTIVE with the United States Patent and Trademark Office. The USPTO has given the VANTIVE trademark a serial number of 98977967. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, April 2, 2026. This trademark is owned by GAMBRO LUNDIA AB. The VANTIVE trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of kidney disease; dietary supplements for the treatment of kidney disease; dialysis fluid for the treatment of kidneys, namely, for use in peritoneal dialysis; pharmaceutical solutions for use in dialysis

Disposable medical devices for use in dialysis machine; Apparatus for preparing dialysis solutions for blood treatment and organ support therapies
vantive

General Information

Serial Number98977967
Word MarkVANTIVE
Filing DateMonday, July 24, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, April 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of kidney disease; dietary supplements for the treatment of kidney disease; dialysis fluid for the treatment of kidneys, namely, for use in peritoneal dialysis; pharmaceutical solutions for use in dialysis
Goods and ServicesDisposable medical devices for use in dialysis machine; Apparatus for preparing dialysis solutions for blood treatment and organ support therapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code005
First Use Anywhere DateFriday, October 11, 2024
First Use In Commerce DateWednesday, December 4, 2024
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code010
First Use Anywhere DateFriday, October 11, 2024
First Use In Commerce DateWednesday, July 30, 2025

Trademark Owner History

Party NameGAMBRO LUNDIA AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLund 22643
SE
Party NameGAMBRO LUNDIA AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLund 22643
SE

Trademark Events

Event DateEvent Description
Thursday, July 27, 2023NEW APPLICATION ENTERED
Tuesday, August 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 6, 2024ASSIGNED TO EXAMINER
Thursday, March 7, 2024NON-FINAL ACTION WRITTEN
Thursday, March 7, 2024NON-FINAL ACTION E-MAILED
Thursday, March 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 10, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 10, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 10, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 10, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 10, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, July 10, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 10, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2024EXAMINER'S AMENDMENT ENTERED
Monday, July 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 8, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, April 8, 2025SOU EXTENSION 1 FILED
Wednesday, April 9, 2025SOU EXTENSION 1 GRANTED
Wednesday, April 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 2, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, September 2, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, October 14, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, October 14, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, October 14, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, March 31, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 14, 2025SOU EXTENSION 2 FILED
Thursday, April 2, 2026SOU EXTENSION 2 GRANTED
Tuesday, October 14, 2025DIVISIONAL REQUEST RECEIVED
Thursday, April 2, 2026DIVISIONAL PROCESSING COMPLETE
Tuesday, September 2, 2025USE AMENDMENT FILED
Tuesday, October 14, 2025USE AMENDMENT FILED
Thursday, April 2, 2026STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

vantive dialysis treatment pharmaceutical solutions disease kidney apparatus machine preparing organ